PCN67 Cost Effectiveness of Zoledronic Acid (ZOL) in Postmenopausal Women With Early Breast Cancer Receiving Adjuvant Letrozole From German and Italian Perspectives
Year: 2012
Type: conference-abstract
Source: Value in Health
Authors: M. Xue, P. Fishman, M. Botteman
Institution: Pharmerit (United States)
Language: English
Topic: Bone health and treatments
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W2025139782
